pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Massachusetts General Hospital

updated 5mo ago

Massachusetts General Hospital is a teaching hospital located in the West End neighborhood of Boston, Massachusetts. It is the original and largest clinical education and research facility of Harvard Medical School/Harvard University, and houses the world's largest hospital-based research program with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagPulmonology8 co-mentions · 6 sources
  • tagPain3 co-mentions · 2 sources
  • tagMonoclonal Antibody2 co-mentions · 2 sources
  • tagType 2 Diabetes2 co-mentions · 1 sources
  • tagAlzheimer's Disease2 co-mentions · 2 sources
  • drugAlzheimer's Disease2 co-mentions · 2 sources
  • tagOncology2 co-mentions · 2 sources
  • tagOphthalmology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
48
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Preclinical: 1
1Preclinical
Preclinical
AAVCOVID
Coronavirus Disease 2019 (COVID-19)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningiomaactive not recruitingn=26
  • N/AAdaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)completedn=10
  • phase1AZD6738 for Patients With Progressive MDS or CMMLactive not recruitingn=52
  • phase2Delayed Tolerance Through Mixed Chimerismrecruitingn=20
  • phase4Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With ADHD and Cannabis Use Disordernot yet recruitingn=66
  • phase1Pemigatinib + Afatinib in Advanced Refractory Solid Tumorsrecruitingn=32
  • phase2Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remissioncompletedn=62
  • phase2Teclistamab In Waldenstrom's Macroglobulinemianot yet recruitingn=24
🐶 Hiring Signal
No open roles indexed yet — view Massachusetts General Hospital jobs →

News

  • London biotech Oyster harvests $60M for tau-targeting brain drugs
    Oyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.
    biopharma_dive · 9d ago
  • Opinion: It took me 13 years to be diagnosed with MS. Christina Applegate’s misdiagnosis doesn’t surprise me
    “I felt Christina Applegate’s disappointment as if it were my own — because not long ago, it was,” writes Lindsay Karp.
    stat · 26d ago
  • How voters feel about trans rights and abortion access will soon be put to the test
    How do voters feel about trans students participating in school sports teams? Or abortion access? The U.S. is about to find out.
    stat · 29d ago
  • The 2026 Biotech Graveyard
    Fierce’s biotech graveyard is an annual tradition in which we remember all the companies we lost over the past year. While we're embracing the spooky spirit of Halloween, we hope the sad stories of…
    fiercebiotech · 1mo ago
  • US to grant up to $125M for personalized RNA manufacturing innovation
    A new program from ARPA-H has devoted funding to make individualized RNA-based genetic medicine more efficient to produce and improve accessibility.
    biospace · 2mo ago
  • Capricor, Replimune illustrate why FDA must listen to rare disease specialists
    Last month’s FDA advisory committee meetings for therapies developed by Capricor Therapeutics and Replimune effectively illustrate the different outcomes for patients when the agency prioritizes sp…
    biospace · 2mo ago
  • CDC releases latest life expectancy data
    Deleted public comments on White House proposals, how Trump cuts are reshaping rural health care, and more Morning Rounds news
    stat · 2mo ago
  • Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
    Following a pair of FDA rejections of its melanoma drug, Replimune’s fortunes flipped today after an advisory committee voted 10 to 3 in favor of the candidate’s effectiveness.
    fiercebiotech · 3mo ago
  • After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
    Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.
    stat · 3mo ago
  • Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
    A new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…
    fiercebiotech · 3mo ago
view all news mentions →
identifiers
source
globaldata
top tags
Infectious Disease1
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?